Chen Xiaobin is currently the Validation Director of Zhejiang Hisun Pharmaceutical Co., Ltd. He holds a bachelor's degree in pharmaceutical preparation from Shenyang Pharmaceutical University and a master's degree in IPEM engineering from Peking University. He has been engaged in the pharmaceutical industry for more than 20 years and has rich experience in project management and official drug regulatory audits. He is committed to the application of statistical methods in quality risk management, solving challenges in practical work, exploring the value of product historical data, and accurately controlling product quality risks. Participated in the preparation of the 2023 edition of the "Guide to Pharmaceutical GMP: APIs".
